About Our Research

Founded in 2023, the Gulbenkian Institute for Molecular Medicine (GIMM) is a pioneering Portuguese private research foundation with an ambitious vision for fundamental scientific exploration and its profound impact on global health and well-being.

GIMM aims to be at the forefront of transdisciplinary research, dedicated to unraveling the fundamental mysteries of life. From the very beginning, GIMM strives for scientific excellence and societal impact, driving the future of molecular medicine for a healthier world.

GIMM was born from the merger of two leading research institutes: Instituto de Medicina Molecular João Lobo Antunes (iMM) and Instituto Gulbenkian de Ciência (IGC). This strategic union combines the strengths, expertise, and resources of both institutes, enhancing our research capabilities and fostering synergies to address complex scientific challenges.